Format

Send to

Choose Destination
Drug Discov Today Technol. 2013 Sep;10(3):e343-50. doi: 10.1016/j.ddtec.2012.04.004.

Technologies: preclinical imaging for drug development.

Abstract

Preclinical imaging with magnetic resonance imaging (MRI), computerised tomography (CT), ultrasound (US), positron emission tomography (PET) or single-photon emission computed tomography (SPECT) enable non-invasive measures of tissue structure, function or metabolism in vivo. The technologies can add value to preclinical studies by enabling dynamic pharmacological observations on the same animal and because of possibilities for relatively direct clinical translation. Potential benefits from the application of preclinical imaging should be considered routinely in drug development.

PMID:
24050130
DOI:
10.1016/j.ddtec.2012.04.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center